Ning Shi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 23
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Co-authors
- Shi‐You Chen (15 shared papers)Xia Guo (4 shared papers)Yiping Zou (17 shared papers)Baohua Hou (3 shared papers)Tingting Ma (2 shared papers)Haosheng Jin (21 shared papers)Man-Ping Wu (2 shared papers)Zhihong Chen (16 shared papers)
- Journals
- Frontiers in Pharmacology (7 papers)Frontiers in Oncology (6 papers)Frontiers in Immunology (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Circulation Research (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Ning Shi
118 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 364
- Oncology 267
- Molecular Biology 672
- Immunology 194
- Immunology and Allergy 32
Countries citing papers authored by Ning Shi
This map shows the geographic impact of Ning Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Shi more than expected).
Fields of papers citing papers by Ning Shi
This network shows the impact of papers produced by Ning Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Shi. The network helps show where Ning Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 105 | |
| 2 | 2020 | 96 | |
| 3 | 2014 | 81 | |
| 4 | 2015 | 80 | |
| 5 | 2019 | 63 | |
| 6 | 2011 | 56 | |
| 7 | 2016 | 51 | |
| 8 | 2015 | 51 | |
| 9 | 2022 | 44 | |
| 10 | 2013 | 44 | |
| 11 | 2015 | 43 | |
| 12 | 2023 | 43 | |
| 13 | Glutamine ameliorates intestinal ischemia-reperfusion Injury in rats by activating the Nrf2/Are signaling pathway. | 2015 | 39 |
| 14 | 2011 | 38 | |
| 15 | 2023 | 34 | |
| 16 | 2016 | 34 | |
| 17 | 2014 | 33 | |
| 18 | 2020 | 32 | |
| 19 | 2007 | 29 | |
| 20 | 2019 | 29 |
About Ning Shi
Ning Shi is a scholar working on Oncology, Cancer Research, Molecular Biology, Hepatology and Gastroenterology, having authored 133 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer-related molecular mechanisms research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Horticultural and Viticultural Research (5 papers), Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (364 citations), Oncology (267 citations), Molecular Biology (672 citations), Immunology (194 citations) and Immunology and Allergy (32 citations). Ning Shi has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Shi‐You Chen, Xia Guo, Yiping Zou, Baohua Hou, Tingting Ma, Haosheng Jin, Man-Ping Wu, Zhihong Chen, Haifeng Lian and Wei‐Bing Xie. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Oncology, Frontiers in Immunology, Arteriosclerosis Thrombosis and Vascular Biology and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.